Search icon Open mobile navigation
Prof. Doug Turnbull's group in Newcastle is investigating the use of IVF techniques to prevent the transmission of mitochondrial DNA disease.
Prof. Doug Turnbull's group in Newcastle is investigating the use of IVF techniques to prevent the transmission of mitochondrial DNA disease.
Prof. Doug Turnbull's group in Newcastle is investigating the use of IVF techniques to prevent the transmission of mitochondrial DNA disease.
Dr Jenny Morgan from UCL Institute of Child Health aims to use models of a particular group of muscular dystrophies - called the dystroglycanopathies - to investigate satellite cell behaviour.
Dr Jenny Morgan from UCL Institute of Child Health aims to use models of a particular group of muscular dystrophies - called the dystroglycanopathies - to investigate satellite cell behaviour.
Dr Jenny Morgan from UCL Institute of Child Health aims to use models of a particular group of muscular dystrophies - called the dystroglycanopathies - to investigate satellite cell behaviour.
Dr Roberts at Kings College London will investigate proteins which interact with dystrophin; the protein which is defective in Duchenne and Becker muscular dystrophy .
Dr Roberts at Kings College London will investigate proteins which interact with dystrophin; the protein which is defective in Duchenne and Becker muscular dystrophy .
Dr Roberts at Kings College London will investigate proteins which interact with dystrophin; the protein which is defective in Duchenne and Becker muscular dystrophy .
Prof George Dickson (Royal Holloway- University of London) and Dr Mathew Wood (University of Oxford) aim to optimise reagents for exon skipping in a project that complements the MDEX clinical trial.
Prof George Dickson (Royal Holloway- University of London) and Dr Mathew Wood (University of Oxford) aim to optimise reagents for exon skipping in a project that complements the MDEX clinical trial.
Prof George Dickson (Royal Holloway- University of London) and Dr Mathew Wood (University of Oxford) aim to optimise reagents for exon skipping in a project that complements the MDEX clinical trial.
Dr Mary Reilly and her colleagues at UCL Institute of Neurology, are studying the effect of exercise regimes on the walking endurance of people with Charcot-Marie-Tooth disease (CMT).
Dr Mary Reilly and her colleagues at UCL Institute of Neurology, are studying the effect of exercise regimes on the walking endurance of people with Charcot-Marie-Tooth disease (CMT).
Dr Mary Reilly and her colleagues at UCL Institute of Neurology, are studying the effect of exercise regimes on the walking endurance of people with Charcot-Marie-Tooth disease (CMT).
This study led by Dr Ros Quinlivan at the RJAH Orthopaedic Hospital in Oswestry proposes to investigate the use of a new ankle foot orthosis to assist walking in boys with Duchenne muscular dystrophy.
This study led by Dr Ros Quinlivan at the RJAH Orthopaedic Hospital in Oswestry proposes to investigate the use of a new ankle foot orthosis to assist walking in boys with Duchenne muscular dystrophy.
This study led by Dr Ros Quinlivan at the RJAH Orthopaedic Hospital in Oswestry proposes to investigate the use of a new ankle foot orthosis to assist walking in boys with Duchenne muscular dystrophy.
Prof Brook, based at the University of Nottingham, completed a two year project where he and his colleagues developed a cell-based drug screen for myotonic dystrophy.
Prof Brook, based at the University of Nottingham, completed a two year project where he and his colleagues developed a cell-based drug screen for myotonic dystrophy.
Prof Brook, based at the University of Nottingham, completed a two year project where he and his colleagues developed a cell-based drug screen for myotonic dystrophy.

Target MD - Issue 1 - 2015

Our first new-look edition of Target MD (Issue 1 of 2015) is now available to read online. You’ll read stories of families we have supported right from the difficult time of diagnosis with a muscle-wasting condition.
Our first new-look edition of Target MD (Issue 1 of 2015) is now available to read online. You’ll read stories of families we have supported right from the difficult time of diagnosis with a muscle-wasting condition.

Campaign Spring 2013

In the first issue of Campaign for 2013, we tell you about one of our founders and longest-standing supporters, Lord Walton, who most deservedly won a 2012 Charity Times Award for Outstanding Individual Achievement.
In the first issue of Campaign for 2013, we tell you about one of our founders and longest-standing supporters, Lord Walton, who most deservedly won a 2012 Charity Times Award for Outstanding Individual Achievement.
Subscribe to